Bioheart
Bioheart, PharmaCell open GMP lab in Europe to support adult stem cell research
Published in Biotech Law Weekly, July 7th, 2006
The lab facility is in compliance with E.U. Good Manufacturing Practices (EU-GMP). This new lab is an advanced research facility that also has GMP cell production capabilities to support research related to Bioheart's adult muscle stem cell technology. Bioheart has developed MyoCell, a cell therapy that involves extracting and culturing cells from a patient's own thigh muscle.
These cells are inserted back into the patient's damaged heart region via the MyoCath, a minimally-invasive injection-catheter system. The research at the lab could lead...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2006-07-07)
More Articles from Biotech Law Weekly
- AHOD, Australia
Research from Australia, Italy and the United States in HIV/AIDS provides new insights - Awards
Humana wins Stevie Award for best new product - Business Update
USIS Commercial Services launches I-9 Employment Eligibility Verification Product - Cerimon Pharmaceuticals
Cerimon Pharmaceuticals names James Welch as chief financial officer - Clinical Data
Clinical Data announces 2006 launch of genetic test for warfarin response - Collegium Pharmaceutical
Collegium Pharmaceutical announces development milestone under Cypress Bioscience agreement - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
